Emilio Bombardieri

11.0k total citations · 2 hit papers
305 papers, 8.0k citations indexed

About

Emilio Bombardieri is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emilio Bombardieri has authored 305 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Radiology, Nuclear Medicine and Imaging, 111 papers in Oncology and 64 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emilio Bombardieri's work include Radiopharmaceutical Chemistry and Applications (77 papers), Medical Imaging Techniques and Applications (68 papers) and Neuroendocrine Tumor Research Advances (50 papers). Emilio Bombardieri is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (77 papers), Medical Imaging Techniques and Applications (68 papers) and Neuroendocrine Tumor Research Advances (50 papers). Emilio Bombardieri collaborates with scholars based in Italy, United States and Netherlands. Emilio Bombardieri's co-authors include Ettore Seregni, Arturo Chiti, Flavio Crippa, Lorenzo Maffioli, Marco Maccauro, Antonia Martinetti, Claudio Chiesa, A. Bogni, Emilio Bajetta and Claudio Pascali and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emilio Bombardieri

297 papers receiving 7.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for radioiodine therapy of differentiated thyroid cancer

2008 474 citations Emilio Bombardieri et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

2012 363 citations Vincenzo Mazzaferro, Claudio Chiesa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emilio Bombardieri Italy	47	3.1k	2.7k	1.8k	1.5k	1.3k	305	8.0k
Cristina Nanni Italy	49	2.7k 0.9×	2.1k 0.8×	1.2k 0.7×	2.6k 1.7×	1.1k 0.8×	257	7.7k
Stanley J. Goldsmith United States	52	4.5k 1.4×	2.4k 0.9×	1.3k 0.7×	3.3k 2.2×	1.5k 1.1×	223	9.2k
Maria Teresa Sandri Italy	41	1.3k 0.4×	4.1k 1.5×	1.2k 0.7×	1.3k 0.9×	889 0.7×	151	9.5k
Umberto Ricardi Italy	48	2.4k 0.8×	2.7k 1.0×	812 0.4×	4.8k 3.2×	2.3k 1.7×	362	10.0k
Kanji Nagai Japan	61	1.8k 0.6×	5.0k 1.9×	1.4k 0.8×	7.1k 4.7×	1.8k 1.3×	281	12.0k
Inne H.M. Borel Rinkes Netherlands	52	1.2k 0.4×	3.1k 1.2×	1.2k 0.7×	2.2k 1.4×	3.6k 2.7×	277	9.4k
Michael Bamberg Germany	45	1.0k 0.3×	1.0k 0.4×	895 0.5×	2.3k 1.5×	1.3k 1.0×	179	6.9k
Philip Rubin United States	59	3.7k 1.2×	2.4k 0.9×	841 0.5×	5.0k 3.3×	2.8k 2.1×	323	11.5k
Bin S. Teh United States	48	1.6k 0.5×	2.0k 0.7×	916 0.5×	4.0k 2.6×	2.0k 1.5×	374	8.4k
Luther W. Brady United States	47	2.1k 0.7×	2.9k 1.1×	1.1k 0.6×	4.4k 2.9×	2.1k 1.6×	342	10.1k

Countries citing papers authored by Emilio Bombardieri

Since Specialization

Citations

This map shows the geographic impact of Emilio Bombardieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Bombardieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Bombardieri more than expected).

Fields of papers citing papers by Emilio Bombardieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Bombardieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Bombardieri. The network helps show where Emilio Bombardieri may publish in the future.

Co-authorship network of co-authors of Emilio Bombardieri

This figure shows the co-authorship network connecting the top 25 collaborators of Emilio Bombardieri. A scholar is included among the top collaborators of Emilio Bombardieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilio Bombardieri. Emilio Bombardieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Albano, Giovanni, et al.. (2024). Medium- and Long-Term Effects of COVID-19 in a Population of Patients Admitted to the Intensive Care Unit: Cognitive and Psychological Sequelae and Quality of Life Six Months and One Year after Discharge. Healthcare. 12(16). 1624–1624. 3 indexed citations

Vitali, Andrea, et al.. (2024). Motion acquisition of gait characteristics one week after total hip arthroplasty: a factor analysis. Archives of Orthopaedic and Trauma Surgery. 144(5). 2347–2356. 3 indexed citations

Trombetta, Claudia Maria, Serena Marchi, Simonetta Viviani, et al.. (2021). Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients. Viruses. 13(7). 1347–1347. 11 indexed citations

Evangelista, Laura, et al.. (2019). The future of choline PET in the era of prostate specific membrane antigen. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(1). 19–28. 10 indexed citations

Seregni, Ettore, Marco Maccauro, Claudio Chiesa, et al.. (2013). Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 223–230. 75 indexed citations

Castellani, Maria Rita, Ettore Seregni, Marco Maccauro, et al.. (2008). MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?. PubMed. 52(4). 430–40. 34 indexed citations

Devizzi, Liliana, Anna Guidetti, Corrado Tarella, et al.. (2008). High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation. Journal of Clinical Oncology. 26(32). 5175–5182. 46 indexed citations

Chiesa, Claudio, Francesca Botta, Angela Coliva, et al.. (2007). Dosimetry in Myeloablative ⁹⁰ Y-Labeled Ibritumomab Tiuxetan Therapy: Possibility of Increasing Administered Activity on the Base of Biological Effective Dose Evaluation. Preliminary Results. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 113–120. 17 indexed citations

Devizzi, Liliana, Ettore Seregni, Anna Guidetti, et al.. (2006). High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.. Blood. 108(11). 3047–3047. 9 indexed citations

10.

Raspagliesi, Francesco, et al.. (2003). False-negative sentinel node in patients with vulvar cancer: A case study. International Journal of Gynecological Cancer. 13(3). 361–363. 3 indexed citations

11.

Bombardieri, Emilio, Cumali Aktolun, Richard P. Baum, et al.. (2003). Breast scintigraphy: procedure guidelines for tumour imaging. European Journal of Nuclear Medicine and Molecular Imaging. 30(12). 1–1. 68 indexed citations

12.

Bajetta, Emilio, Antonia Martinetti, Nicoletta Zilembo, et al.. (2002). Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. Annals of Oncology. 13(7). 1059–1066. 37 indexed citations

13.

Sole, Angelo Del, Andrea Falini, Laura Ravasi, et al.. (2001). Anatomical and biochemical investigation of primary brain tumours. European Journal of Nuclear Medicine and Molecular Imaging. 28(12). 1851–1872. 46 indexed citations

14.

Turatti, Fabio, Delia Mezzanzanica, Elena Nardini, et al.. (2001). Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2. Cancer Immunology Immunotherapy. 49(12). 679–686. 8 indexed citations

15.

Bombardieri, Emilio, et al.. (2001). . Annals of Oncology. 12(2suppl). 51–61. 14 indexed citations

16.

Thomas, Lothar, H. Leyh, Michael Marberger, et al.. (1999). Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer.. PubMed. 45(4). 472–7. 87 indexed citations

17.

Bajetta, Emilio, Leonardo Ferrari, Antonia Martinetti, et al.. (1999). Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 86(5). 858–865. 220 indexed citations

18.

Bajetta, Emilio, Nicoletta Zilembo, Sandro Barni, et al.. (1997). A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results. Annals of Oncology. 8(7). 649–654. 11 indexed citations

19.

Bombardieri, Emilio, Maurizio Gabrielli, Paolo Veronesi, et al.. (1992). Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology. The International Journal of Biological Markers. 7(1). 35–42. 9 indexed citations

20.

Buraggi, G.L., Emilio Bombardieri, Massimo Gasparini, et al.. (1987). Radioimmunodetection of melanoma. 31(1). 37–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact